Reducing the intake of calories by up to 40% has long been known to have a beneficial effect on animal health: the animals live longer, blood-sugar levels drop faster, and they burn more body fat. According to an article by a group of researchers recently published in the research magazine Cell Metabolism, many of these changes in the body are brought about by gut bacteria(*).
Transferring microbes from the gut
The international team led by Mirko Trajkovski, SNSF professor at the University of Geneva, restricted the calorie intake of mice for 30 days and found an increased amount of beige fat, a type of fat tissue that burns body fat and contributes to weight loss.
Interestingly, when they transferred the caecum microbial communities from the calorie-restricted mice to other mice raised and still living in sterile conditions (i.e. without microbes in their gut), the receiving animals also developed more beige fat and were leaner despite eating normally. So the change of the microbiome alone created health benefits for the mice.
When analysing these microbial communities, Trajkovski’s team found that the gut bacteria of mice on a calorie-restricted diet produced lower levels of a toxic molecule called Lipopolysaccharide (LPS). When the LPS-levels were reconstituted to normal levels in the blood, the mice lost many health benefits of the diet.
New compounds may help in treating obesity
The bacterial LPS molecule is known to trigger an immune response by activating a specific signal receptor known as the Toll-like receptor 4 (TLR4). Experimenting on mice with genetically modified immune cells lacking this receptor, the researchers were able to mimic the effect of the caloric restriction. „Clearly the immune system not only combats infections, it also plays a key role in regulating metabolism,“ says Trajkovski. Apart from more beige fat and weight loss, the mice react better to insulin, their livers process sugar and fat in healthier ways and the mice are better equipped to withstand colder temperatures. „This is turning into an entirely new field of research,“ says Trajkovski.
Having dissected the mechanism behind caloric restriction, the researchers set out to test two compounds: one of them directly reduces toxic LPS production by the bacteria and the other blocks the TLR4 receptor that receives the LPS signal. Both had a positive effect on the mice that was similar to that of eating less. „It may one day become possible to treat obese people with a drug that simulates caloric restriction,“ says Trajkovski. „We are currently investigating the precise changes in bacterial communities, and we are also testing other compounds that reduce LPS production and signalling.“
The study was funded by the Swiss National Science Foundation (SNSF), the European Research Council (ERC) the Clayton Foundation and the Louis-Jeantet Foundation and conducted by researchers from the University of Geneva, AstraZeneca IMED Biotech Unit in Gothenburg (Sweden) and Inselspital Bern.
contact for scientific information:
Prof. Mirko Trajkovski
Centre Médical Universitaire (CMU)
Universite de Genève
Phone: +41 22 37 95 256
(*) S. Fabbiano et. al: Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements. Cell Metabolism (2018). DOI: 10.1016/j.cmet.2018.08.005